Cargando…
At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598226/ http://dx.doi.org/10.1016/j.brs.2021.10.367 |
| _version_ | 1784600772442324992 |
|---|---|
| author | Huffman, Sarah Badran, Bashar Dancy, Morgan Austelle, Christopher Kautz, Steven George, Mark |
| author_facet | Huffman, Sarah Badran, Bashar Dancy, Morgan Austelle, Christopher Kautz, Steven George, Mark |
| author_sort | Huffman, Sarah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8598226 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85982262021-11-18 At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms. Huffman, Sarah Badran, Bashar Dancy, Morgan Austelle, Christopher Kautz, Steven George, Mark Brain Stimul Article Published by Elsevier Inc. 2021 2021-11-18 /pmc/articles/PMC8598226/ http://dx.doi.org/10.1016/j.brs.2021.10.367 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Huffman, Sarah Badran, Bashar Dancy, Morgan Austelle, Christopher Kautz, Steven George, Mark At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms. |
| title | At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms. |
| title_full | At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms. |
| title_fullStr | At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms. |
| title_full_unstemmed | At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms. |
| title_short | At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms. |
| title_sort | at-home telemedicine controlled tavns twice daily for 4 weeks is feasible and safe for long covid symptoms. |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598226/ http://dx.doi.org/10.1016/j.brs.2021.10.367 |
| work_keys_str_mv | AT huffmansarah athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT badranbashar athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT dancymorgan athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT austellechristopher athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT kautzsteven athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms AT georgemark athometelemedicinecontrolledtavnstwicedailyfor4weeksisfeasibleandsafeforlongcovidsymptoms |